StockData
RadNet, Inc. logo

RadNet, Inc. (RDNT) bonds

RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3058% above fair value
$74.92−1.97 (-2.56%)

Close on Nov 17, 2026Market cap $5.90BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$1.33B
$30.67M due within a year
Net debt
$606.26M
After $726.27M of cash
Implied interest rate
6.64%
FY2025 interest ÷ average debt
Interest coverage
0.9×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in RadNet's 10-Q for the period ended Jun 30, 2026

IssueCarrying value
Equipment notes payable at 2.7% to 7.2%, due through 2029, collateralized by medical equipment$17.60M
First Lien Term Loan$1.21B
NJIN Term Loan Agreement$118.13M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeAvailableDrawn
Barclays Credit Agreement$282.00M$273.40M–
Barclays Term Loan–––
First Lien Credit Agreement Eighth Amendment$50.00M$50.00M–
Revolving Credit Facility––$0

See a number that looks wrong?